4.82
Cumberland Pharmaceuticals Inc stock is traded at $4.82, with a volume of 313.96K.
It is up +19.25% in the last 24 hours and up +99.58% over the past month.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
See More
Previous Close:
$4.00
Open:
$4.02
24h Volume:
313.96K
Relative Volume:
2.63
Market Cap:
$71.79M
Revenue:
$37.79M
Net Income/Loss:
$-10.38M
P/E Ratio:
-6.6027
EPS:
-0.73
Net Cash Flow:
$-1.00M
1W Performance:
+20.45%
1M Performance:
+99.58%
6M Performance:
+51.43%
1Y Performance:
+108.30%
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Name
Cumberland Pharmaceuticals Inc
Sector
Phone
615-255-0068
Address
1600 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CPIX
Cumberland Pharmaceuticals Inc
|
4.80 | 59.83M | 37.79M | -10.38M | -1.00M | -0.73 |
|
ZTS
Zoetis Inc
|
129.41 | 57.01B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.79 | 49.57B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.24 | 45.02B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.12 | 35.57B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
503.39 | 21.08B | 3.08B | 1.24B | 1.07B | 25.61 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-12-12 | Reiterated | UBS | Neutral |
| Feb-01-11 | Reiterated | UBS | Neutral |
| Dec-16-10 | Downgrade | UBS | Buy → Neutral |
| Aug-17-10 | Downgrade | Jefferies | Buy → Hold |
| Aug-17-10 | Reiterated | Morgan Joseph | Buy |
| Aug-17-10 | Reiterated | UBS | Buy |
| May-14-10 | Reiterated | Morgan Joseph | Buy |
View All
Cumberland Pharmaceuticals Inc Stock (CPIX) Latest News
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Crosses Above 200 Day Moving AverageHere's What Happened - MarketBeat
Cumberland reports progress in DMD heart disease trial - MSN
Is Cumberland Pharmaceuticals Inc. stock near bottom after declineTake Profit Strategies & Invest Like A Pro - Bollywood Helpline
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
What drives Cumberland Pharmaceuticals Inc stock priceExit Strategy Tips & Unlock Long-Term Capital Growth Ideas - earlytimes.in
6-Day Rally Sends Cumberland Pharmaceuticals Stock Up 77% - Trefis
Is Cumberland Pharmaceuticals Inc. stock dividend yield sustainable2025 Market Sentiment & Weekly High Momentum Picks - Улправда
Top Research Reports for NVIDIA, Netflix & Merck - Yahoo Finance
Can Cumberland Pharmaceuticals Inc. stock beat market expectations this quarter - Улправда
Zacks Initiates Coverage of CPIX With Outperform Recommendation - sharewise.com
Cumberland Pharmaceuticals Stock On Fire: Up 76% With 5-Day Winning Streak - Trefis
Does Cumberland Pharmaceuticals Inc. stock trade at a discount to peers - Улправда
Cumberland Pharmaceuticals Leads 3 Promising Penny Stocks - Yahoo Finance
Is Cumberland Pharmaceuticals Inc a good long term investmentDouble Top/Bottom Patterns & Free Dynamic Capital Growth - earlytimes.in
CPIX FinancialsIncome Statement - Quiver Quantitative
Cumberland Pharmaceuticals Earnings Notes - Trefis
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Shares Fly 26% But Investors Aren't Buying For Growth - simplywall.st
Cumberland Pharmaceuticals Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Cumberland (Nasdaq: CPIX) gets CMS price-linked J-code for Caldolor injection - Stock Titan
CALDOLOR® (IBUPROFEN) INJECTION CMS ISSUED J-CODE NOW ASSOCIATED WITH REIMBURSEMENT PRICE SUPPORTING NON-OPIOID PAIN MANAGEMENT - Yahoo Finance
Cumberland Pharmaceuticals (NASDAQ:CPIX) versus Pyxis Oncology (NASDAQ:PYXS) Critical Comparison - Defense World
Financial Review: Cumberland Pharmaceuticals (NASDAQ:CPIX) & Crinetics Pharmaceuticals (NASDAQ:CRNX) - Defense World
Is Cumberland Pharmaceuticals Inc. stock cheap compared to fundamentals2025 Market Outlook & Risk Managed Investment Strategies - Newser
CPIX SEC FilingsCumberland Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
What is the fair value of Cumberland Pharmaceuticals Inc. stock now2025 Top Gainers & Daily Price Action Insights - Newser
How strong is Cumberland Pharmaceuticals Inc. stock revenue growth2025 Trading Volume Trends & Fast Moving Trade Plans - Newser
Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Debt In A Risky Way? - simplywall.st
Cumberland Pharmaceuticals Inc Stock Analysis and ForecastMarket Breadth Indicators & Breakout Portfolio Performance - earlytimes.in
Hepatic Encephalopathy Market Analysis and Forecast, 2025-2035 - GlobeNewswire Inc.
Nasdaq Moves: Is Cumberland Pharmaceuticals Inc. stock dividend yield sustainableJuly 2025 Reactions & Stock Market Timing Techniques - BỘ NỘI VỤ
Cumberland Pharmaceuticals Inc. Announces First Amendment to Amended and Restated Revolving Credit Note and Second Amendment to Amended and Restated Revolving Credit Loan Agreement - marketscreener.com
Cumberland Pharmaceuticals Inc. (CPIX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
CPIX amends Pinnacle Bank revolver, $25M capacity, SOFR +2.75% - Stock Titan
How Cumberland Pharmaceuticals Inc. stock performs in interest rate cyclesJuly 2025 Decliners & High Conviction Buy Zone Picks - newser.com
Is Cumberland Pharmaceuticals Inc. stock positioned for long term growthJuly 2025 Closing Moves & Proven Capital Preservation Tips - newser.com
Is Cumberland Pharmaceuticals Inc. forming a reversal patternMarket Activity Summary & Fast Exit/Entry Strategy Plans - newser.com
How Cumberland Pharmaceuticals Inc. stock valuations compare to rivalsJuly 2025 Price Swings & Capital Efficient Trade Techniques - newser.com
Is Cumberland Pharmaceuticals Inc. stock safe for conservative investorsJuly 2025 Setups & Daily Stock Trend Watchlist - newser.com
Is Cumberland Pharmaceuticals Inc. stock trading near support levelsJuly 2025 Highlights & Fast Moving Market Watchlists - newser.com
Visual analytics tools that track Cumberland Pharmaceuticals Inc. performanceWeekly Market Report & Daily Technical Forecast Reports - newser.com
Cumberland Pharmaceuticals Reports Revenue Growth and Strategic Expansions - MSN
Price action breakdown for Cumberland Pharmaceuticals Inc.Market Volume Report & Entry Point Confirmation Signals - newser.com
Cumberland Pharmaceuticals Inc Stock (CPIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):